Cervical Dysplasia Market, By Diagnosis Type (Diagnosis Test (HPV Test, Pap Smear Test, Biopsy Test) and Diagnostic Device (Colposcope)), By End User (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jan 2024

Code : CMI1486

Pages :145

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Cervical Dysplasia MarketSize and Trends

The Cervical Dysplasia Market size is expected to reach US$ 1,105.4 Mn by 2030, from US$ 675 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period. Cervical dysplasia is a condition in which abnormal cells grow on the surface of the cervix. Without treatment, cervical dysplasia can lead to cervical cancer. With early detection and treatment, the growth of these abnormal cells can be prevented from becoming cancerous.

Cervical Dysplasia Market Drivers:

Growing prevalence of cervical dysplasia globally: Increasing prevalence of cervical dysplasia globally is expected to drive the market growth over the forecast period. For instance, according to the data published by the Springer Nature in August 10, 2023, global prevalence estimation of high-grade cervical dysplasia was 4.3%, and the global prevalence estimate of low-grade cervical dysplasia was 6.2%. The highest prevalence of cervical dysplasia was reported in the European continent.
Increasing government initiatives: Increasing government initiatives and increasing awareness programs will aid in the market growth over the forecast period. For instance, in May 2018, the World Health Organization (WHO) Director-General announced a global call for action to eliminate cervical cancer, In August 2020, the World Health Assembly adopted the global strategy for cervical cancer elimination.
Increasing government funding: The cervical dysplasia market is experiencing significant growth due to rising government focus and funding towards cervical cancer prevention programs around the world. Various governments are allocating increased healthcare budgets for nationwide screening and vaccination initiatives to curb the rising cervical cancer burden. For example, governments in the U.S., U.K., Australia, and Canada have invested over US$500 Mn cumulatively between 2020-2022 for cervical screening programs and human papillomavirus infection (HPV) vaccination drives according to data published by OECD and WHO.

Cervical Dysplasia Market Trends:

Increased adoption of HPV vaccination: human papillomavirus infection (HPV) vaccination programs led by governments and health organizations have strengthened over the years. For example, in the U.S.A., HPV vaccination completion rates among eligible adolescents increased from 48.6% in 2017 to 60.5% in 2020, as per reports from center for disease control and prevention (CDC). Similarly, countries like the U.K., Australia, and some European nations have observed vaccination coverage of over 80%, among young females, due to sustained school-based immunization drives. This widespread use of HPV vaccines means fewer girls and women will develop precancerous cervical lesions later in their lives.